- Home
- DNTH vs BBN Comparison
DNTH vs BBN Comparison
Compare DNTH & BBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- BBN
- Stock Information
- Founded
- DNTH 2015
- BBN 1983
- Country
- DNTH United States
- BBN United States
- Employees
- DNTH N/A
- BBN N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- BBN Finance Companies
- Sector
- DNTH Health Care
- BBN Finance
- Exchange
- DNTH Nasdaq
- BBN Nasdaq
- Market Cap
- DNTH 1.0B
- BBN 1.0B
- IPO Year
- DNTH N/A
- BBN N/A
- Fundamental
- Price
- DNTH $37.04
- BBN $16.53
- Analyst Decision
- DNTH Strong Buy
- BBN
- Analyst Count
- DNTH 9
- BBN 0
- Target Price
- DNTH $61.57
- BBN N/A
- AVG Volume (30 Days)
- DNTH 969.3K
- BBN 231.8K
- Earning Date
- DNTH 11-06-2025
- BBN 01-01-0001
- Dividend Yield
- DNTH N/A
- BBN 6.90%
- EPS Growth
- DNTH N/A
- BBN N/A
- EPS
- DNTH N/A
- BBN N/A
- Revenue
- DNTH $4,854,000.00
- BBN N/A
- Revenue This Year
- DNTH N/A
- BBN N/A
- Revenue Next Year
- DNTH N/A
- BBN N/A
- P/E Ratio
- DNTH N/A
- BBN N/A
- Revenue Growth
- DNTH 17.87
- BBN N/A
- 52 Week Low
- DNTH $13.37
- BBN $14.33
- 52 Week High
- DNTH $38.59
- BBN $18.36
- Technical
- Relative Strength Index (RSI)
- DNTH 82.86
- BBN 58.67
- Support Level
- DNTH $36.00
- BBN $16.48
- Resistance Level
- DNTH $24.81
- BBN $16.72
- Average True Range (ATR)
- DNTH 2.70
- BBN 0.12
- MACD
- DNTH 1.31
- BBN 0.01
- Stochastic Oscillator
- DNTH 90.18
- BBN 60.78
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest
BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation.